Ophthalmologic essentials

Article

Breaking news from the floor

Latest in laser generation
SCHWIND has launched the new AMARIS 750S laser system, a further development of the portfolio of laser systems and presented a new concept laser system that the company claims could mean a paradigm shift in refractive and therapeutic corneal surgery

The intracameral cefuroxime/moxifloxacin debate
Per Montan introduced delegates to his own unique critical look at the peer-reviewed journals which have covered the cefuroxime/moxifloxacin debate.

A new kind of flexibility
Visitors to Geuder’s booth have experienced the company’s latest system for anterior and posterior segment surgeries, the Megatron S4, as well as a new marking system for toric IOLs, an improved non-toxic staining solution for IOL peel and a brand new intraocular LED light source.

More news from the congress

Two does become one!The shape of things to comeSmall incisions

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Subscribe Now!
Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Related Content
Precautionary class 2 medicines recall of Zaditen 0.25 mg/ml, eye drops, solution, issued

Precautionary class 2 medicines recall of Zaditen 0.25 mg/ml, eye drops, solution, issued

Kassi Filkins
July 8th 2025
Article

A precautionary recall of Zaditen eye drops is issued due to potential microbial contamination, affecting batch 4V64. No adverse events reported.

PHOTON Results and Their Relation to DME Patients in Your Practice

PHOTON Results and Their Relation to DME Patients in Your Practice

July 25th 2024
Podcast

John Kitchens, MD, is joined by Diana Do, MD, to discuss the PHOTON trial results and their relation to patients with diabetic macular oedema in clinical practice.

A man in a bed takes a pill. Concept image for oral therapy, danegaptide non proliferative diabetic retinopathy medication. Image credit: ©Jelena – stock.adobe.com

Breye Therapeutics completes phase 1B trial of danegaptide oral therapy for diabetic retinopathy

Lynda Charters
July 8th 2025
Article

Investigators reported the oral therapy was well-tolerated in trials for early treatment of non-proliferative diabetic retinopathy and associated oedema

PULSAR Results and Their Relation to nAMD Patients in Your Practice

PULSAR Results and Their Relation to nAMD Patients in Your Practice

July 24th 2024
Podcast

John Kitchens, MD, is joined by David Brown, MD, to discuss the PULSAR study results and their relation to patients with neovascular age-related macular degeneration in clinical practice.

The International Space Station (ISS) pictured in orbit above Earth. Concept image for International Spectralis Symposium conference meeting in Heidelberg, Germany, and NASA. ©Paopano – stock.adobe.com

Long-duration spaceflight tests the limits of telemedicine

Sheryl Stevenson;Steven Laurie, PhD
July 3rd 2025
Article

In-orbit imaging drives innovation in terrestrial telemedicine, the NASA scientist explained

A group of older elderly people exercise outdoors. Concept image for dry eye disease and aging, demographics of Tear Film and Ocular Surface Society TFOS DEWS III Digest report. Image credit: ©Rido – stock.adobe.com

Interdisciplinary report illuminates demographic, systemic health factors of dry eye disease

Jordana Joy
July 2nd 2025
Article

Remaining questions about DED pertain to geographic considerations, prevalence measures for DED in children and the design of future studies to determine risk factors in patients under 40

© 2025 MJH Life Sciences

All rights reserved.